ATLANTA, Dec. 27, 2016 -- Oxford Industries, Inc. (NYSE:OXM) today announced the Company will be presenting at the ICR Conference 2017 being held at the JW Marriott Orlando Grande Lakes in Orlando, Florida.
The Company's presentation is scheduled to begin at 3:00 p.m. Eastern Time on Tuesday, January 10, 2017. The presentation will be webcast and can be accessed via the Oxford website at www.oxfordinc.com.
About Oxford
Oxford Industries, Inc., a leader in the apparel industry, owns and markets the distinctive Tommy Bahama®, Lilly Pulitzer® and Southern Tide® lifestyle brands. Oxford also produces certain licensed and private label apparel products. Oxford's stock has traded on the New York Stock Exchange since 1964 under the symbol OXM. For more information, please visit Oxford's website at www.oxfordinc.com.
Contact: Anne M. Shoemaker Telephone: (404) 653-1455 Fax: (404) 653-1545 E-mail: [email protected]


Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Apple Turns 50: From Garage Startup to AI Crossroads
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



